# TAS2R42

## Overview
TAS2R42 is a gene that encodes the protein taste 2 receptor member 42, which is part of the bitter taste receptor family. These receptors are G protein-coupled receptors (GPCRs) that play a crucial role in the perception of bitter compounds. TAS2R42 is primarily expressed in the taste buds but has also been identified in extragustatory tissues, suggesting potential roles beyond taste perception (Harris2024Extragustatory). The protein encoded by TAS2R42 is involved in detecting bitter substances, which can trigger aversive responses to potentially harmful compounds. Genetic variations in TAS2R42 have been linked to differences in taste perception and susceptibility to certain thyroid-related conditions, highlighting its significance in both sensory biology and clinical contexts (Choi2018Genetic; Wooding2022Global).

## Clinical Significance
TAS2R42, a bitter taste receptor, has been implicated in various thyroid-related conditions. Polymorphisms in TAS2R42 are associated with differing levels of free serum T3 and T4, which are critical thyroid hormones (Harris2024Extragustatory). A retrospective study found that TAS2R42 was differentially expressed in patients with Hashimoto's thyroiditis, suggesting a potential role in autoimmune thyroid conditions (Harris2024Extragustatory). Additionally, the TAS2R3/4 CC haplotype, which includes TAS2R42, is linked to reduced concentrations of triiodothyronine (T3) and offers protection against papillary thyroid carcinoma (PTC) (Choi2018Genetic). This haplotype may alter the efficacy of receptor variants, influencing thyroid function and potentially reducing PTC risk (Choi2018Genetic). 

The genetic diversity of TAS2R42, including nonsynonymous polymorphisms, suggests potential functional variations that could impact taste perception and related health conditions (Wooding2022Global). However, the precise mechanisms by which TAS2R42 influences these diseases remain unclear, and further research is needed to confirm these associations and explore potential therapeutic applications (Choi2018Genetic).


## References


[1. (Harris2024Extragustatory) Jacob C. Harris, Robert J. Lee, and Ryan M. Carey. Extragustatory bitter taste receptors in head and neck health and disease. Journal of Molecular Medicine, September 2024. URL: http://dx.doi.org/10.1007/s00109-024-02490-0, doi:10.1007/s00109-024-02490-0. This article has 0 citations.](https://doi.org/10.1007/s00109-024-02490-0)

[2. (Choi2018Genetic) Jeong-Hwa Choi, Jeonghee Lee, Sarah Yang, Eun Kyung Lee, Yul Hwangbo, and Jeongseon Kim. Genetic variations in tas2r3 and tas2r4 bitterness receptors modify papillary carcinoma risk and thyroid function in korean females. Scientific Reports, October 2018. URL: http://dx.doi.org/10.1038/s41598-018-33338-6, doi:10.1038/s41598-018-33338-6. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-018-33338-6)

[3. (Wooding2022Global) Stephen P. Wooding and Vicente A. Ramirez. Global population genetics and diversity in the tas2r bitter taste receptor family. Frontiers in Genetics, October 2022. URL: http://dx.doi.org/10.3389/fgene.2022.952299, doi:10.3389/fgene.2022.952299. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2022.952299)